The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Carl Zeiss Meditec; Merck Serono; Roche Pharma AG
Consulting or Advisory Role - Noxxon Pharma
Research Funding - Carl Zeiss Meditec
Travel, Accommodations, Expenses - Carl Zeiss Meditec
Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme.
 
Frank Anton Giordano
No Relationships to Disclose
 
Grit Welzel
No Relationships to Disclose
 
Julian Emanuel Gehweiler
No Relationships to Disclose
 
Stefanie Brehmer
No Relationships to Disclose
 
Jens-Uwe Appelt
Employment - Qiagen
 
Andreas von Deimling
No Relationships to Disclose
 
Marcel Seiz-Rosenhagen
No Relationships to Disclose
 
Peter Schmiedek
No Relationships to Disclose
 
Frederik K. Wenz
Honoraria - Carl Zeiss Meditec; Celgene; Elekta; Lilly; Medtronic; Roche
Consulting or Advisory Role - Elekta
Research Funding - Carl Zeiss Meditec (Inst); Elekta (Inst); opasca (Inst)
Patents, Royalties, Other Intellectual Property - Co-development of IORT with Carl Zeiss Meditec
Travel, Accommodations, Expenses - Carl Zeiss Meditec; Celgene; Elekta; Lilly; Roche; Sennewald GmbH